Drug Profile
Research programme: lactate dehydrogenase A inhibitors - Genentech
Alternative Names: GNE-140Latest Information Update: 28 Nov 2018
Price :
$50
*
At a glance
- Originator Genentech
- Class Piperidines; Small molecules
- Mechanism of Action Lactate dehydrogenase 5 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Nov 2018 No recent reports of development identified for research development in Cancer in USA
- 09 Oct 2014 Early research in Cancer in USA (unspecified route)